Symptom clusters may identify cancer patients at risk for hospitalizationJuly 23, 2018Patient & Survivor CarePractice Management
Breast cancer patients don’t get the financial counseling they want from their cliniciansJuly 23, 2018Breast Cancer
FDA approves Nivestym, second biosimilar to NeupogenJuly 20, 2018Patient & Survivor CareLeukemia, Myelodysplasia, Transplantation
FDA approves IDH1 inhibitor for relapsed/refractory AMLJuly 20, 2018Leukemia, Myelodysplasia, Transplantation
Ibrutinib stacks up well on safety in pooled analysisJuly 20, 2018Leukemia, Myelodysplasia, Transplantation
PARP inhibitors didn’t impair QOL as ovarian cancer maintenance therapyJuly 20, 2018Gynecologic CancerPatient & Survivor Care
FDA expands indication for ribociclib for advanced breast cancerJuly 18, 2018Breast CancerMetastatic Breast Cancer
